The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
The Lupus Research Alliance seeks to fund biomedical research that will discover better diagnostics, improve medical treatments and advance translational and clinical research that will ultimately lead to a cure for lupus. Our grant funding opportunities provide distinct opportunities for researchers to test their most innovative hypothesis by applying cutting edge methodologies to further investigation in the lupus and autoimmune space.
Lupus Innovation Award (formerly known as the Novel Research Grant): up to $150,000/year total costs for up to 2 years. Provides support for pioneering, high-risk, high-reward approaches to major challenges in lupus research. Special emphasis is placed on lupus studies exploring fundamental mechanisms, novel targets and pathways, novel technologies, and interdisciplinary approaches. Both early career and established investigators new to lupus with highly innovative ideas are encouraged to apply. Early stage investigators are eligible for an additional third year of funding contingent upon successful completion of the original grant.
Lupus Mechanisms and Targets Award (formerly known as the Target Identification in Lupus grant): up to $200,000/year total costs for up to three years. Supports highly meritorious research focused on the identification and/or investigation of molecular pathways or targets that will lead to new or improved therapies for patients with lupus.
The same research project may not be submitted for consideration to both grant mechanisms. Such submissions will be triaged without review.
Deadline: Jan. 15, 2020